Status:
COMPLETED
Photobiomodulation Laser Therapy for COVID-19 Positive Patients With Pulmonary Disease
Lead Sponsor:
Lowell General Hospital
Conditions:
COVID-19
Eligibility:
All Genders
18-90 years
Phase:
PHASE2
Brief Summary
The aim of this study is to evaluate the effectiveness of MLS laser therapy as a treatment for pulmonary complications due to COVID-19 infection.
Detailed Description
Participants will be randomized into treatment vs. control group. Both groups will receive regular inpatient medical treatment. Participants in the experimental arm will receive laser treatments once ...
Eligibility Criteria
Inclusion
- COVID-19 positive
- Pulmonary compromise requiring oxygen support of approximately 2-6 liters
- Able to self prone, or support in self-sitting position
Exclusion
- Ventilator management
- Patients with autoimmune disorders or inflammatory conditions not related to COVID-19
- Pregnant women
Key Trial Info
Start Date :
April 30 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 16 2020
Estimated Enrollment :
10 Patients enrolled
Trial Details
Trial ID
NCT04391712
Start Date
April 30 2020
End Date
July 16 2020
Last Update
August 5 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lowell General Hospital
Lowell, Massachusetts, United States, 01854